Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Codal-Synto Ltd, 21 Constantinoupoleos, 3011 Limassol, Cyprus
Syntoclav 1.2g powder for solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection or infusion. White or almost white sterile powder for reconstitution as an intravenous injection or infusion. |
Each vial of Syntoclav 1.2g sterile powder contains 1000mg of amoxicillin (as amoxicillin sodium) and 200mg of clavulanic acid (as potassium clavulanate).
This product does not contain any excipients (see section 6.1).
| Active Ingredient | Description | |
|---|---|---|
| Amoxicillin |
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
|
| Clavulanic acid |
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
| List of Excipients |
|---|
|
None. |
20ml Glass vials Type II; packs of 1, 5, 10, 25, 50 and 100 vials are available.
Not all pack sizes may be marketed.
Codal-Synto Ltd, 21 Constantinoupoleos, 3011 Limassol, Cyprus
21586
20/08/2012 / 21/12/2020
| Drug | Countries | |
|---|---|---|
| SYNTOCLAV | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
